Post by
RockMaschine on Apr 23, 2021 9:32am
Boom IMCC revenue reported
Q4 of 4.9 million with over 50% margin. Q1 expected ay 8+ growing to 15-18 in Q2. MYM likely to report $5+ million end of month as well.
Comment by
biketrader98 on Apr 24, 2021 3:11pm
So MYM=IM from a revenue perspective. That's not good for getting yes votes.
Comment by
NLMoose on Apr 24, 2021 7:41pm
Based on IM Cannabis' financials, including a $5 million EBITDA loss as opposed to a profit to reflect on its higher year for year sales, MYM Nutraceuticals' minority shareholders would be wise not to endorse this takeover.